10:45 AM - 10:55 AM
[O4-1] A reversible albumin-binding once-weekly growth hormone (GH) treatment (somapacitan; NNC0195-0092) induces a dose-dependent IGF-I response similar to daily GH therapy in children with growth hormone deficiency (GHD)
The password will be announced in the abstract book.